One-Year Efficacy and Safety of Proton-Beam Irradiation Combined with Intravitreal Conbercept for Refractory or Recurrent Polypoidal Choroidal Vasculopathy: A Pilot Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6528
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
One-Year Efficacy and Safety of Proton-Beam Irradiation Combined with Intravitreal Conbercept for Refractory or Recurrent Polypoidal Choroidal Vasculopathy: A Pilot Study ; volume:11 ; number:1 ; day:13 ; month:11 ; year:2021 ; pages:187-199 ; date:2.2022
Ophthalmology and therapy ; 11, Heft 1 (13.11.2021), 187-199, 2.2022
- Creator
-
Guo, Jingli
Qiu, Xianxin
Tang, Wenyi
Xu, Gezhi
Moyers, Michael. F.
Ren, Wei
Xing, Ying
Gao, Jin
Sun, Jiayao
Lu, Jiade
Kong, Lin
Liu, Wei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-021-00409-3
- URN
-
urn:nbn:de:101:1-2022050109101113485372
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guo, Jingli
- Qiu, Xianxin
- Tang, Wenyi
- Xu, Gezhi
- Moyers, Michael. F.
- Ren, Wei
- Xing, Ying
- Gao, Jin
- Sun, Jiayao
- Lu, Jiade
- Kong, Lin
- Liu, Wei
- SpringerLink (Online service)
Other Objects (12)
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Choroidal nevus and polypoidal vasculopathy: case series
One-year outcomes of fixed-dosing Aflibercept therapy for pre treated and naive polypoidal choroidal vasculopathy patient
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Choroidal nevus and polypoidal vasculopathy: case series
One-year outcomes of fixed-dosing Aflibercept therapy for pre treated and naive polypoidal choroidal vasculopathy patient
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Choroidal nevus and polypoidal vasculopathy: case series
One-year outcomes of fixed-dosing Aflibercept therapy for pre treated and naive polypoidal choroidal vasculopathy patient
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen